Senzime AB Uppsala

Senzime develops and markets systems driven by unique algorithms and sensors to monitor patient muscle function and electrical impulses—before, during and after surgery. The company’s solution is called TetraGraph, a medical device system that digitally and continuously measures the level of neuromuscular blockade in the patient. Our goal is improved clinical precision and simplified management in health care. By preventing complications and enabling care staff to follow care guidelines and drug recommendations, TetraGraph® helps shorten hospitalizations and reduce the costs of health care.